- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05297357
Complementary Weaning With Adult Food Typical of the Mediterranean Diet
March 22, 2022 updated by: Dario Bruzzese, Federico II University
Complementary Weaning With Adult Food Typical of the Mediterranean Diet and it Effect on Taste Development and Eating Habits of Children
A Randomized Controlled Clinical Trials was conducted to study the medium-long term impact of a complementary weaning using adult foods typical of Mediterranean Diets (MD) on children taste development and eating habits, and on the microbiota composition.
Main objectives were to assess the effect of such weaning scheme on:
- medium-long term adherence of the children to the MD (Primary aim).
- familial eating habits to verify how many changes may come from an early education of the kid toward a Mediterranean eating style
- the BMI of the children
- gut microbiota composition
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
394
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
4 months to 6 months (Child)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Infants, either breast fed or formula fed between 4 and 6 months of age
- Informed consent from at least one parent
Exclusion Criteria:
- Infants either with associated comorbidities or with low birth weight
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control group
|
|
|
Experimental: Mediterranean Diet group
|
Kids in experimental group were weaned by using fresh foods traditionally used in MD and appropriately adapted to infants including seasonal fruit and vegetables, various kinds of fresh blue fish, spices and herbs.
No salt was used while a small amount of Parmesan cheese was added.
No sugar was added to any meal.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proportions of children showing a good adherence (i.e. KidMed score >= 8) to Mediterranean diet
Time Frame: 36 months
|
KidMed is a questionnaire measuring Mediterranean Diet Quality for children and adolescents.
The final score ranges from from 0 to 12 where scores >=8 indicates optimal Mediterranean diet; score within range 4-7 suggest that an improvement is needed to adjust intake to Mediterranean patterns and score <=3 indicate very low diet quality.
|
36 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Average of the KidMed score
Time Frame: 36 months
|
36 months
|
|
|
Average children's BMI
Time Frame: 36 months
|
36 months
|
|
|
Proportion of overweight and obese children
Time Frame: 36 months
|
Overweight and obesity were defined according to extra-centiles of the Italian BMI growth norms published in Cacciari et al. 2006.
|
36 months
|
|
Variation of microbial communities between arms based on Bray-Curtis dissimilarity
Time Frame: 48 months
|
Bray-Curtis dissimilarity estimates difference in microbial abundances between two samples.
It ranges from 0 to 1.
The greater the index value the larger the difference in species abundances between groups.
|
48 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2015
Primary Completion (Actual)
July 1, 2016
Study Completion (Actual)
December 31, 2019
Study Registration Dates
First Submitted
March 12, 2022
First Submitted That Met QC Criteria
March 22, 2022
First Posted (Actual)
March 28, 2022
Study Record Updates
Last Update Posted (Actual)
March 28, 2022
Last Update Submitted That Met QC Criteria
March 22, 2022
Last Verified
March 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- 213
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.